Bristol-Myers Squibb Becomes Oversold

January 21, 2017   |   January 2017 Bond Updates
Bristol-Myers Squibb Co. an even more interesting and timely stock to look at, is the fact that in trading on Friday, shares of BMY entered into oversold territory, changing hands as low as $49.62 per share. We define oversold territory using the Relative Strength Index

View more at: http://www.forbes.com/sites/dividendchannel/2017/01/20/bristol-myers-squibb-becomes-oversold-3/
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/